Dengue Vaccination

The New Dengue Vaccination Dengvaxia® available in Chiang Mai, Thailand.

21 DEC 2016
Dengue Vaccination

Dengvaxia® from Sanofi Pasteur is now available in Chiang Mai at CM Mediclinic. The Dengvaxia® vaccination also known as CYD-TDV is a live recombinant tetravalent dengue vaccine that prevents dengue fever in humans.

Dengue fever, sometimes referred to as breakbone fever is a mosquito-borne tropical disease caused by the dengue virus. Manifestation of the fever can vary from mild symptoms which are often mistaken for the flu or other viral infections to more serious symptoms such as hemorrhagic fever which can lead to death. The fight against dengue is now aided by this vaccine that hopefully can save over 25000 lives worldwide each year. Dengvaxia is administered subcutaneously in a three-dose regimen over a 12-month period on a 0/6/12 month schedule. But please note Dengvaxia® is only for use in people from 9 to 45 years of age who have been infected with dengue virus before and who live in areas where this infection is endemic. If you require any further information regarding Dengvaxia® or would like to arrange appointment for the vaccination please do not hesitate to contact us.


PROTECT YOURSELF AGAINST DENGUE WITH THE DENGVAXIA® VACCINE

Copyrights ©2014-2020: CM Mediclinic Co.,Ltd.  All Rights Reserved.  Website Design By J&J Vision